Louisiana on Alert as COVID Treatment Gets Nationwide Recall

LAFAYETTE, La. (KPEL News) - A drug commonly used for the treatment of COVID-19 is currently under a nationwide recall, and Louisiana patients may want to be careful with their injections.

Veklury, better known as remdesivir, is a Gilead product, but according to the Food and Drug Administration (FDA), there have been complaints about glass particles found in the 100 mg vials of the drug.

Get our free mobile app

According to the FDA, injecting a product contaminated with glass particles can cause localized irritation or swelling as the body reacts to the foreign material. More concerning, however, is the potential for these tiny glass fragments to enter the bloodstream, where they can travel to vital organs such as the heart, lungs, or brain.

This can lead to dangerous blockages in blood vessels, significantly raising the risk of severe complications, including stroke or even death. Despite the seriousness of this issue, the FDA says, Gilead has announced that, as of now, no reports of adverse effects have been linked to this recall.

The FDA says that Gilead is reaching out to its distributors and customers by sending UPS Next Day airmail to pharmacies, ensuring the swift return of any remaining vials from the affected lot of Veklury® (remdesivir) for Injection 100 mg/vial.

Below is a table laying out the details of the recall.

Healthcare facilities in possession of the recalled medicine should immediately cease using the affected batch and follow the return instructions provided in Gilead’s notification letter.

For any inquiries related to this recall, consumers and healthcare professionals can contact Gilead Medical Information at 1-866-633-4474, available Monday through Friday from 5 a.m. to 6 p.m. PST, or visit their website at www.askgileadmedical.com. If you have experienced any issues that might be connected to this medication, it’s advised to consult with your physician or healthcare provider promptly.